+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic and genetic alterations in mammary stroma: implications for tumour progression



Phenotypic and genetic alterations in mammary stroma: implications for tumour progression



Breast Cancer Research 3(6): 373-379



In addition to the well documented role of cytokines in mediating tissue-level interactions, it is now clear that matrix macromolecules fulfil a complementary regulatory function. Data highlighted in the present review extend the repertoire of matrix signalling mechanisms, (1) introducing the concept of 'matrikines', these defined as proteinase-generated fragments of matrix macromolecules that display cryptic bioactivities not manifested by the native, full-length form of the molecule, and (2) indicating that a previously identified motogenic factor (migration stimulating factor [MSF]) produced by foetal and cancer patient fibroblasts is a genetically generated truncated isoform of fibronectin, which displays bioactivities cryptic in all previously identified fibronectin isoforms. These observations are discussed in the context of the contribution of a 'foetal-like' stroma to the progression of breast cancer.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973869

Download citation: RISBibTeXText

PMID: 11737888


Related references

Phenotypic responses of mouse mammary tumours and normal mammary epithelium cultured in collagen gels: Correlation with tumour type and progression. Tissue and Cell 24(6): 879-894, 1992

Chronic and low doses exposure of environmental pollutants induces phenotypic alterations in a tumour progression model of breast cancer. European Journal of Cancer 50: S136-S137, 2014

Proliferative behaviour of an oestrogen sensitive rat mammary tumour: evidence for a paracrine interaction between tumour and stroma. British Journal of Cancer 67(1): 107-111, 1993

Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Convergent Science Physical Oncology 3:, 2017

Involvement of genetic alterations in breast tumour progression to hormone independence in vitro. Endocrine Related Cancer 2(1): 123-126, 1995

Genetic alterations in four cases of canine mammary tumours: two trisomies, translocations and one tumour suppressor gene p53 mutation. Archivos de Zootecnia 45(170-171): 315-321, 1996

LW106, a novel indoleamine 2,3-dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma-immune crosstalk and cancer stem cell enrichment in tumour micro-environment. British Journal of Pharmacology 175(14): 3034-3049, 2018

Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications. Schizophrenia Research 188: 98, 2017

Stroma activation and angiogenesis in tumour progression. EJC Suppl.s 1(5): S227, 2003

Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Research 60(9): 2562-2566, 2000

Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Research 3(4): 218-223, 2001

Ras/MAP kinase activation of Ets2 in mammary stroma promotes tumor progression. Proceedings of the American Association for Cancer Research Annual Meeting 43: 152, 2002

Fibroma of the breast: a rare tumour in the spectrum of the benign spindle cell tumours of the mammary stroma. Polish Journal of Pathology 69(2): 189-194, 2018

Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages. Histopathology (oxford). 29(5): 411-419, 1996

Host--tumour relationship. XX. The hexosamine content of the tumour as a marker of relations between the tumour stroma and tumour cells. Neoplasma 12(4): 373-378, 1965